Document Detail

Secondary patency of thrombosed prosthetic vascular access grafts with aggressive surveillance, monitoring and endovascular management.
MedLine Citation:
PMID:  18603454     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: To study the long-term patency of thrombosed prosthetic vascular access grafts treated with percutaneous mechanical thrombectomy (PMT) followed by aggressive surveillance and monitoring and repeated endovascular interventions. STUDY DESIGN: Two hundred seven vascular access grafts presented with first-time thrombosis were treated with PMT using the AngioJet device (n=185) or the Arrow-Trerotola percutaneous thrombolytic device (n=22) followed by angioplasty (+/- stenting) of the anatomical lesion responsible for the thrombotic event. Clinical success was considered at least one successful subsequent hemodialysis session. Graft surveillance/monitoring included clinical and hemodialysis parameters to detect a failing or thrombosed graft. RESULTS: PMT was technically successful in 202 cases (97.6%) and clinically successful in 193 cases (93.2%). During follow-up, 149 got thrombosed and either abandoned (n=33) or underwent at least once repeat thrombectomy (n=116); finally 100 grafts were abandoned (n=90), ligated (n=5) or removed (n=5). Endovascular management (0.54 procedures per 100 graft-days, thrombectomy, n=307 sessions and angioplasty, n=162 sessions) increased significantly functional assisted-primary patency rates from 29% and 14% at 1 and 2 years to a secondary patency of 62% and 47%, respectively. Secondary patency was worse in loop grafts (P=.02) and intermediate graft thrombosis (occurred between 31-182 days after graft placement, P<.001) and better when renal failure was due to hypertension or diabetes (compared to other or cryptogenic causes, P=.048) or isolated angioplasty for graft dysfunction during follow-up had been performed (P<.001). Multivariate analysis identified intermediate graft thrombosis and isolated angioplasty as independent predictors of secondary patency (P<.001, relative risk 2.77 and P<.001, relative risk 0.28, respectively). CONCLUSIONS: PMT is a highly successful procedure with acceptable long-term secondary patency results, provided that aggressive endovascular management of subsequent thrombotic or dysfunction episode is performed. Further research to identify the causes of intermediate graft thrombosis is justified.
S K Kakkos; G K Haddad; J A Haddad; M M Scully
Related Documents :
9551074 - Formation of myointimal hyperplasia and cytokine production in experimental vein grafts.
21095134 - Clinical value of intra-operative transit-time flow measurement for coronary artery byp...
3035644 - Low-dose streptokinase in the treatment of arterial graft occlusions.
6388704 - Doppler ultrasound in the evaluation of experimental microvascular grafts.
2280584 - Spontaneous recanalization of a pseudoocclusion of the internal carotid artery in a 70-...
21990594 - Does treatment modality affect vasospasm distribution in aneurysmal subarachnoid hemorr...
Publication Detail:
Type:  Journal Article     Date:  2008-07-07
Journal Detail:
Title:  European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery     Volume:  36     ISSN:  1532-2165     ISO Abbreviation:  Eur J Vasc Endovasc Surg     Publication Date:  2008 Sep 
Date Detail:
Created Date:  2008-08-19     Completed Date:  2008-09-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9512728     Medline TA:  Eur J Vasc Endovasc Surg     Country:  England    
Other Details:
Languages:  eng     Pagination:  356-65     Citation Subset:  IM    
Division of Vascular Surgery, Department of Surgery, Henry Ford Hospital, Detroit, MI 48202, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arteriovenous Shunt, Surgical / adverse effects*
Blood Vessel Prosthesis / adverse effects*
Graft Occlusion, Vascular / etiology,  surgery*
Middle Aged
Thrombectomy / instrumentation,  methods*
Thrombosis / etiology,  surgery*
Vascular Patency

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Avoidance learning facilitates temporal processing in the primary auditory cortex.
Next Document:  The development of a real-time PCR assay for the quantification of Leishmania infantum DNA in canine...